What $350,000 Insider Sale Signals Mineralys Investors
A high-profile insider sale at Mineralys raises questions about what it might mean for the biotech's near-term trajec...
Innovative Skincare Clinical
Innovative Skincare Clinical presents study results and product evaluations to help you assess effectiveness and safety in modern skincare.
1,166 articlesUniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Biotechnology Stock Nearly Doubled: VIR Insight Today
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
Better Obesity Drug Race: Novo Nordisk vs Lilly 2026
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Citi Flags Agilent Technologies, Trims Icon Target
Citi issued a life sciences sector note that elevates Agilent Technologies while reducing Icon PLC’s target, signalin...
Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Beyond (XAIR) 2026 Earnings: Q4 Review and Outlook
A clear, actionable look at beyond (xair) 2026 earnings and what a Q4 earnings call could reveal. Learn how to read t...
Health Startup Noom Adding GLP-1 Drugs to Med Plan Now
Noom is shifting from psychology-based weight loss to prescription treatments, launching Noom Med in a multi-state ro...
Daré (DARE) 2025 Earnings: A Clear Path for Investors
Daré (DARE) has a developing pipeline and a tight cash runway. This article breaks down what the Q4 2025 earnings cal...
What Know About This Palvella Insider Sale After 476K Rally
Palvella Therapeutics just saw a notable insider move after a multi-hundred percent rally. This guide breaks down the...
Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status
Rate Lock Hold Time Penalties